Vaishali Pharma share price

  • NaN%Low risk
  • NaN%Moderate risk
  • NaN%Balanced risk
  • NaN%High risk
  • NaN%Extreme risk
  • 12.05(-1.07%)
    June 24, 2025 15:29:51 PM IST
    • NSE
    • BSE
  • Vol : 1.41M (NSE + BSE)
    Last 20 day avg : 468.95 K

Vaishali Pharma is trading -1.07% lower at Rs 12.05 as compared to its last closing price. Vaishali Pharma has been trading in the price range of 12.50 & 12.00. Vaishali Pharma has given -30.36% in this year & -6.09% in the last 5 days. The company posted a net profit of -4.29 Crores in its last quarter.Listed peers of Vaishali Pharma include Aarey Drugs & Pharmaceuticals (4.96%), Bal Pharma (-1.81%), Vaishali Pharma (-1.07%).The Mutual Fund holding in Vaishali Pharma was at -% in . The MF holding has - from the last quarter. The FII holding in Vaishali Pharma was at 0.02% in 17 May 2024. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Key Metrics

Updated on Jun 24, 2025, 01:05 PM UTC

  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    2.45
    Lower than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    0.00
    Higher than historical values
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.69
    Low volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.19
    Higher than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
12.00
Highest
12.50
52 week range
Lowest
10.30
Highest
24.91
Vaishali Pharma Financials
Financials
Financials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
View all
  • Income
  • Balance Sheet
  • Cash Flow
Loading...
Units in the chart are in crores
Insights
  • Financial
  • Valuation
    No Data
    Financial insights for Vaishali Pharma are currently unavailable
    Please check back later.
Vaishali Pharma Technical Analysis
Pivot Level - classic
Info
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
  • R1
  • 13.44
  • R2
  • 14.20
  • R3
  • 14.89
Pivot12.75
  • S1
  • 11.99
  • S2
  • 11.30
  • S3
  • 10.54
Short Term
Info
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Info
Considers price movement over the last 6 months
Not Available
  • Very Bearish
  • Bearish
  • Neutral
  • Very Bullish
  • Bullish
Trends unavailable at the moment.
Vaishali Pharma Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Aarey Drugs & Pharmaceuticals
Bullish
62.404.96176.9330.951.15-1.43
Bal Pharma
Bearish
97.21-1.81154.7721.812.051.2140.58
Vaishali Pharma
Bearish
12.05-1.07129.1740.192.5-7.12
Mangalam Drugs And Organics
Bearish
79.68-127.0318.780.85-7.89
Take Solutions
Bearish
8.511.92125.89168.756.06--
Vaishali Pharma Shareholding
View All
Shareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
    No Data
    Shareholding pattern for Vaishali Pharma is currently unavailable
    Please check back later.
    Shareholding Insights
    • InsightsPromoter(s) does not have a high stake in the company
    • InsightsPromoter(s) have decreased the stake in the company in last 12 months
    • InsightsFIIs are not invested in this company
    • InsightsMutual Funds are not invested in this company.
    Vaishali Pharma Corporate Actions
    View all
    • Board Meetings
    • AGM
    • Dividends
    • Bonus
    • Split
    • Rights
    Meeting DatePurpose
    2025-05-28Audited Results & Others
    2025-02-06Quarterly Results & Others
    2025-01-28Others
    2025-01-06Quarterly Results & Others
    2024-11-14Quarterly Results
    About the company Vaishali Pharma
    • IndustryBiotechnology & Drugs
    • ISININE972X01022
    • BSE Code
    • NSE CodeVAISHALI
    Vaishali Pharma Limited is an India-based pharmaceutical company. The Company is in the pharmaceutical business, mainly dealing in active pharmaceutical ingredients, pharmaceutical formulations, surgical products, and veterinary supplements, operating in domestic and export markets. Its product categories include active pharmaceutical ingredients (APIs), formulation brands, formulations, herbal, nutraceutical, oncology, surgical, and veterinary. The Company has manufactured and exported approximately 250 formulations and specializes in manufacturing tailor-made formulations. It offers APIs, including antibiotics, anti-ulcer, anti-inflammatory/analgesic/ anti-pyretic, anti-malarial, cardiac, anti-diabetic, anti-cold/anti-allergic, antiviral, antifungal, skeletal muscle relaxant, and anthelmintic drugs, excipients, topical steroids, corticosteroids, and enzymes. It has a global presence in Asia & Pacific, Africa, the Commonwealth of Independent States, America, and the Middle East.
    • Management Info
    • Atul VasaniChairman of the Board, Managing Director
    • Hemanth PathakChief Executive Officer
    • Ratnesh SinghChief Financial Officer
    • Akshay JharkhandiCompany Secretary & Compliance Officer
    • Jagruti VasaniWhole Time Director
    Vaishali Pharma Share Price FAQs

    Vaishali Pharma is trading at 12.05 as on Tue Jun 24 2025 09:59:51. This is -1.07% lower as compared to its previous closing price of 12.18.

    The market capitalization of Vaishali Pharma is 129.17 Cr as on Tue Jun 24 2025 09:59:51.

    The 52 wk high for Vaishali Pharma is 24.91 whereas the 52 wk low is 10.30

    Vaishali Pharma can be analyzed on the following key metrics -

    • TTM P/E:
    • Sector P/E: 22.54
    • Dividend Yield: 0.00%
    • D/E ratio: 0.19

    Vaishali Pharma reported a net profit of 0.82 Cr in 2025.